The molecular virology of coronaviruses

Ella Hartenian(University of California, Berkeley), Divya Nandakumar(University of California, Berkeley), Azra Lari(University of California, Berkeley), Michael Ly(University of California, Berkeley), Jessica M. Tucker(University of California, Berkeley), Britt A. Glaunsinger(Howard Hughes Medical Institute)
Journal of Biological Chemistry
July 13, 2020
Cited by 560Open Access
Full Text

Abstract

Few human pathogens have been the focus of as much concentrated worldwide attention as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19. Its emergence into the human population and ensuing pandemic came on the heels of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), two other highly pathogenic coronavirus spillovers, which collectively have reshaped our view of a virus family previously associated primarily with the common cold. It has placed intense pressure on the collective scientific community to develop therapeutics and vaccines, whose engineering relies on a detailed understanding of coronavirus biology. Here, we present the molecular virology of coronavirus infection, including its entry into cells, its remarkably sophisticated gene expression and replication mechanisms, its extensive remodeling of the intracellular environment, and its multifaceted immune evasion strategies. We highlight aspects of the viral life cycle that may be amenable to antiviral targeting as well as key features of its biology that await discovery.


Related Papers

No related papers found

Powered by citation graph analysis